Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on April 15, 2025 it granted stock options to purchase an aggregate of 60,670 shares of common stock and 40,888 restricted stock units…

Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO--(BUSINESS WIRE)--Airgain, Inc. (NASDAQ: AIRG), a leading provider of advanced wireless connectivity solutions that drive cutting-edge innovation in 5G technology, today announced that it has granted inducement awards to one new employee who ... L'articolo Airgain® Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) è un contenuto originale di 01net.

Marshall Wace LLP Has $101.29 Million Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Marshall Wace LLP grew its stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 14.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,153,313 shares of the biopharmaceutical company’s stock after buying an additional 279,612 shares during the quarter. Marshall Wace LLP’s holdings in Cytokinetics were worth $101,292,000 as of its most recent SEC filing. Several other institutional investors and hedge…